USE OF PROLACTIN INHIBITOR COMPOUNDS FOR ADJUSTMENT OF THE CIRCADIAN RHYTHM OF PROLACTIN.

摘要

A PROCESS FOR LONG-TERM MODIFICATION AND REGULATION OF LIPID METABOLISM - GENERALLY TO REDUCE OBESITY, RESISTANT TO INSULIN, HYPERINSULINEMIA OR HYPERGLYCEMIA, OR BOTH (THESE ARE THE BRANDS OF THE CONTRAST OF NON-INS AND INSPIRES FROM TYPE II DIABETES) BY ADMINISTRATION (BY EXAMPLE: BY FEEDING OR INJECTING IN THE BLOOD CURRENT) TO AN ANIMAL OR HUMAN DOPAMINE AGONIST VERTEBRATE, BY EXAMPLE: BROMOCRIPTINE. BROMOCRIPTINE IS GIVEN ON A LIMITED PERIOD OF ONCE A DAY DEPENDING ON THE NORMAL CIRCADIAN RHYTHM OF THICK AND THIN MEMBERS OF SIMILAR SPECIES. THE TREATMENT WILL RESULT IN A DECREASE IN THE FATS OF THE BODY OF THE OBESE SPECIES IN A DAILY TIME SEQUENCE BASED ON THE CIRCADIAN RHYTHMS OF PROLACTIN MAXIMA, OR OF MAXIMUM PROLACTIN AND GLUCOCORTICOSTEROID, OF THE SANGLE LEVEL. THIN MEMBERS OF SIMILAR SPECIES, INSULIN RESISTANCE HYPERINSULINEMIA AND HYPERGLYCEMIA, OR BOTH, MAY ALSO BE CONTROLLED IN HUMANS BY A LONG-TERM TREATMENT CORRESPONDING TO THAT FOR OBESITY. DAILY SHORT-TIME INJECTIONS RE-SET A HORMONAL TIME IN THE NEURAL CENTERS OF THE BRAIN TO PRODUCE LONG-TIME EFFECTS.